Advertisement

Reactions Weekly

, Volume 1752, Issue 1, pp 17–17 | Cite as

Adalimumab/infliximab

Demyelinating disease: 4 case reports
Case report
  • 19 Downloads

Reference

  1. Lee HJ, et al. Demyelination amongst patients exposed to tumour necrosis factor-alpha inhibitor (TNFi): A case series. International Journal of Rheumatic Diseases 22 (Suppl. 3): 121 (plus poster) abstr. 3-067, Apr 2019. Available from: URL: http://doi.org/10.1111/1756-185X.13545 [abstract] - Australia

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations